VYOME HOLDINGS, INC. Capital Expenditures
VYOME HOLDINGS, INC. (HIND) reported Capital Expenditures of $1.43 thousand for the 6-month period ending 2024-06-30, per its 8-K filed 2025-09-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-09-02
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $54.00K, a 64.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was -$209.00K, a 21000.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $171.00K, a 11.86% decline from fiscal 2019.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $194.00K, a 84.87% decline from fiscal 2018.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $1.28M, a 22.91% increase from fiscal 2017.
- VYOME HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $1.04M, a 196.31% increase from fiscal 2016.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.43K 8-K · filed 2025-09-02 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $54.00K derived: sum of 2 quarters · filed 2021-05-12 | $54.00K derived: sum of 3 quarters · filed 2021-05-12 | -$155.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $54.00K derived: sum of 2 quarters · filed 2021-03-12 | -$155.00K derived: sum of 3 quarters · filed 2021-03-12 | $171.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$209.00K derived: sum of 2 quarters · filed 2020-11-06 | $117.00K 10-Q · filed 2020-11-06 | $267.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | -$209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $117.00K 10-Q · filed 2020-07-30 | $267.00K derived: sum of 3 quarters · filed 2021-05-12 | $291.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $326.00K 10-Q · filed 2021-05-12 | $476.00K derived: sum of 2 quarters · filed 2021-05-12 | $500.00K derived: sum of 3 quarters · filed 2021-05-12 | $501.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $174.00K derived: sum of 2 quarters · filed 2021-03-12 | $175.00K derived: sum of 3 quarters · filed 2021-03-12 | $194.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $25.00K derived: sum of 2 quarters · filed 2020-11-06 | $44.00K 10-Q · filed 2020-11-06 | $459.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $20.00K 10-Q · filed 2020-07-30 | $435.00K derived: sum of 3 quarters · filed 2020-07-30 | $645.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $19.00K 10-Q · filed 2020-06-19 | $434.00K derived: sum of 2 quarters · filed 2020-06-19 | $644.00K derived: sum of 3 quarters · filed 2020-06-19 | $943.00K derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $625.00K derived: sum of 2 quarters · filed 2020-02-27 | $924.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.28M 10-K · filed 2020-02-27 |
| 2018-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $509.00K derived: sum of 2 quarters · filed 2019-11-08 | $867.00K 10-Q · filed 2019-11-08 | $1.01M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $657.00K 10-Q · filed 2019-07-24 | $796.00K derived: sum of 3 quarters · filed 2019-07-24 | $1.14M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $358.00K 10-Q · filed 2019-05-10 | $497.00K derived: sum of 2 quarters · filed 2019-05-10 | $842.00K derived: sum of 3 quarters · filed 2019-05-10 | $1.02M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $484.00K derived: sum of 2 quarters · filed 2019-02-22 | $662.00K derived: sum of 3 quarters · filed 2019-02-22 | $1.04M 10-K · filed 2019-02-22 |
| 2017-09-30 | $345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $523.00K derived: sum of 2 quarters · filed 2018-11-02 | $904.00K 10-Q · filed 2018-11-02 | $997.00K derived: sum of 4 quarters · filed 2018-11-02 |
| 2017-06-30 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $559.00K 10-Q · filed 2018-08-02 | $652.00K derived: sum of 3 quarters · filed 2018-08-02 | $848.00K derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $381.00K 10-Q · filed 2018-05-10 | $474.00K derived: sum of 2 quarters · filed 2018-05-10 | $670.00K derived: sum of 3 quarters · filed 2018-05-10 | $688.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $289.00K derived: sum of 2 quarters · filed 2018-03-05 | $307.00K derived: sum of 3 quarters · filed 2018-03-05 | $352.00K 10-K · filed 2018-03-05 |
| 2016-09-30 | $196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $214.00K derived: sum of 2 quarters · filed 2017-11-03 | $259.00K 10-Q · filed 2017-11-03 | $315.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $63.00K 10-Q · filed 2017-08-02 | $119.00K derived: sum of 3 quarters · filed 2018-03-05 | |
| 2016-03-31 | $45.00K 10-Q · filed 2017-05-10 | $101.00K derived: sum of 2 quarters · filed 2018-03-05 | ||
| 2015-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $139.00K 10-K · filed 2018-03-05 | ||
| 2015-09-30 | $83.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $268.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |